Showing results (71-80 of 240) with videos related to
Sort By:
Pageof 24
Journal of Neurology|January 22, 2008
Contribution of relapses to disability in multiple sclerosisClaire Hirst, Gillian Ingram, Owen Pearson, et al.Cerebellum (London, England)|July 25, 2012
Human mesenchymal stem cells increase anti-oxidant defences in cells derived from patients with Friedreich's ataxiaRimi Dey, Kevin Kemp, Elizabeth Gray, et al.Journal of Alzheimer'S Disease : JAD|May 1, 2013
Endothelin-converting enzyme-1 activity, endothelin-1 production, and free radical-dependent vasoconstriction in Alzheimer's diseaseJennifer C Palmer, Hannah M Tayler, Seth LoveBrain Pathology (Zurich, Switzerland)|September 28, 2004
The pathogenesis of neonatal post-hemorrhagic hydrocephalusShobha Cherian, Andrew Whitelaw, Marianne Thoresen, et al.Brain Research|September 18, 2010
Kallikrein-related peptidase 6 in Alzheimer's disease and vascular dementiaEmma L Ashby, Patrick G Kehoe, Seth LoveNeurobiology of Aging|November 16, 2010
Assessment of activation of the plasma kallikrein-kinin system in frontal and temporal cortex in Alzheimer's disease and vascular dementiaEmma L Ashby, Seth Love, Patrick G KehoeBrain Pathology (Zurich, Switzerland)|August 16, 2013
Convection-enhanced drug delivery to the brain: therapeutic potential and neuropathological considerationsNeil U Barua, Steven S Gill, Seth LoveJournal of Neuroscience Methods|January 29, 2008
Immunocapture-based fluorometric assay for the measurement of insulin-degrading enzyme activity in brain tissue homogenatesJames Scott Miners, Patrick Gavin Kehoe, Seth LoveBrain Pathology (Zurich, Switzerland)|October 11, 2015
Pathophysiology of Hypoperfusion of the Precuneus in Early Alzheimer's DiseaseJ Scott Miners, Jennifer C Palmer, Seth LoveNeuropathology and Applied Neurobiology|January 7, 2015
Synaptic protein levels altered in vascular dementiaLindsey I Sinclair, Hannah M Tayler, Seth LovePageof 24